Skip to main content

Table 3 Different vaccine administration routes: intradermal vs. subcutaneous lymph node uptake

From: Evaluation of in vivo labelled dendritic cell migration in cancer patients

Patients

mDC × 106

Administration route

Isotope

Max uptake (%) *

R.L. (no. 7)

4

Intradermal

99m Tc-HMPAO

0.95

G.D. (no. 8)

4

Intradermal

99m Tc-HMPAO

1.02

R.L. (no. 7)

4

Subcutaneous

99m Tc-HMPAO

0.30

G.D. (no. 8)

4

Subcutaneous

99m Tc-HMPAO

0.37

  1. UPTAKE RATIO: intradermal/subcutaneous average: 3 *Maximum uptake = maximum lymph node activity/inoculation site activity at 0 h